Objective The MuNanoVac STREP project will assess a new vaccine strategy to prevent HIV-1 infection based on a primo-vaccination using a biodegradable synthetic colloidal carrier made of poly-lactic acid (PLA) nanoparticles covered with adsorbed antigens. The aim is to demonstrate that PLA nanoparticles are a perfect mucosal vaccine vehicle, immunogenic for both arms of immunity, adaptable to many types of antigens, easy and simple to produce. Such nanoparticle-based vaccine carriers will allow targeting dentritic cells or transporting the vaccine through skin or mucosal epithelial barriers. To amplify the mucosal immune response, the project will investigate the potential use of immuno-modulator molecules associated with different immunization routes and schedules. Six main technical activities will be conducted in the project: 1) Elaborating a standardized formulation process of PLA nanoparticles with selected HIV-1 antigens, gag and trimeric gp140 2) Identifying the best adjuvant among four candidates to potentiate the mucosal immune responses induced by PLA formulations 3) Optimizing the uptake of nanoparticles by mucosa or skin and the orientation of the immune response 4) Defining the best immunization routes and schedules of nanoparticle formulation in presence or absence of immuno-modulators for immune responses 5) Testing safety and mucosal immunity of the two best combinations in rabbits and 6) Evaluating the vaccine strategy efficacy studies with rectal and vaginal challenge routes in non human primates. Additional activities will include dissemination and exploitation of results, IPR and societal issues. The MuNanoVac project will contribute to advancing a promising vaccine approach for HIV, that could prove versatile enough for application to other poverty-related diseases e.g. Tuberculosis. With the proposed vaccine candidate, the project gives Europe a tremendous opportunity to gain leadership in the use of biodegradable nanoparticles for vaccine carriers. Fields of science engineering and technologyindustrial biotechnologybiomaterialsbioplasticspolylactic acidmedical and health sciencesbasic medicineimmunologyimmunisationmedical and health scienceshealth sciencesinfectious diseasesRNA virusesHIVmedical and health sciencesbasic medicinepharmacology and pharmacypharmaceutical drugsvaccinesengineering and technologynanotechnologynano-materials Programme(s) FP6-LIFESCIHEALTH - Life sciences, genomics and biotechnology for health: Thematic Priority 1 under the Focusing and Integrating Community Research programme 2002-2006. Topic(s) LSH-2005-2.3.0-10 - SME-driven innovations for poverty-related diseases Call for proposal FP6-2005-LIFESCIHEALTH-7 See other projects for this call Funding Scheme STREP - Specific Targeted Research Project Coordinator PHUSIS EU contribution No data Address Espace Randon 58 route du Rivet SAINT ISMIER France See on map Links Website Opens in new window Total cost No data Participants (7) Sort alphabetically Sort by EU Contribution Expand all Collapse all CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE France EU contribution No data Address Rue Michel-Ange 3 PARIS See on map Links Website Opens in new window Total cost No data ST GEORGE'S HOSPITAL MEDICAL SCHOOL United Kingdom EU contribution No data Address Cranmer Terrace LONDON See on map Links Website Opens in new window Total cost No data PALACKY UNIVERSITY IN OLOMOUC Czechia EU contribution No data Address Krizkovského 8 OLOMOUC See on map Links Website Opens in new window Total cost No data CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN Germany EU contribution No data Address Schumannstraße 20/21 BERLIN See on map Links Website Opens in new window Total cost No data COMMISSARIAT À L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES France EU contribution No data Address 31-33 rue de la Fédération PARIS See on map Links Website Opens in new window Total cost No data HOSPITAL CLÍNIC I PROVINCIAL DE BARCELONA Spain EU contribution No data Address Villarroel, 170 BARCELONA See on map Total cost No data UNIVERSITÉ PIERRE ET MARIE CURIE - PARIS 6 France EU contribution No data Address 4 place de jussieu PARIS See on map Links Website Opens in new window Total cost No data